切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Rho-kinase - MET - NMDA receptor - D4 Receptors

12件产品中的 1-10

页面
每页
清除全部
  1. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  2. Pramipexole
    B1488 Pramipexole
    中文名: 普拉克索
    Target: D2 Receptors|D3 Receptors|D4 Receptors
    Summary: 多巴胺激动剂
      ≥10.57 mg/mL
      insoluble in H2O
  3. BMS-794833
    B1438 BMS-794833
    Target: MET|Flk-1
    Summary: Met/VEGFR2抑制剂
      ≥23.45 mg/mL
      insoluble in H2O
  4. Clozapine
    B2235 Clozapine
    中文名: 氯氮平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 Receptors
    Summary: 5-HT受体拮抗剂
      ≥14.95 mg/mL
      insoluble in H2O
  5. Thioridazine HCl
    A8537 Thioridazine HCl
    中文名: 盐酸硫利达嗪,盐酸硫代利哒,甲硫达嗪盐酸盐,甲硫哒嗪盐酸盐
    Target: Cytochrome P450 (CYP450)|D1 and D5 Receptors|D2 Receptors|D3 Receptors|D4 Receptors
    Summary: 钙通道蛋白抑制剂
      ≥20.35 mg/mL
      ≥6.78 mg/mL
  6. MK-2461
    A8476 MK-2461
    Target: FLT3|PDGFR|MET|Ron
    Summary: C-Met(野生型/突变型)抑制剂
      ≥24.8 mg/mL
      insoluble in H2O
  7. Tivantinib (ARQ 197)
    A8325 Tivantinib (ARQ 197)
     2 Citation
    Target: MET
    Summary: C-Met抑制剂
      ≥18.47 mg/mL
      ≥2.29 mg/mL
  8. BMS-777607
    A5703 BMS-777607
    Target: MET
    Summary: 强效的c-Met选择性抑制剂
      ≥25.65 mg/mL
      insoluble in H2O
  9. SGX-523
    A1196 SGX-523
     1 Citation
    Target: MET
    Summary: 高度选择性的、ATP竞争性的Met抑制剂
      ≥17.95 mg/mL
  10. SU11274
    A2678 SU11274
     2 Citation
    Target: MET
    Summary: C-Met抑制剂
      ≥28.4 mg/mL
      insoluble in H2O

12件产品中的 1-10

页面
每页